共 77 条
[1]
Parekh WA(2015)Approach to assessing the economic impact of insulin-related hypoglycaemia using the novel local impact of hypoglycaemia tool Diabetic Med 32 1156-1166
[2]
Ashley D(2017)The economic burden of insulin-related hypoglycemia in Spain Diabetes Ther 8 899-913
[3]
Chubb B(2014)Incidence and correlates of hypoglycemia in type 2 diabetes. The Hypos-1 study J Diabetes Metab 5 344-853
[4]
Gillies H(2015)Incidence and risk factors for severe and symptomatic hypoglycemia in type 1 diabetes. Results of the HYPOS-1 study Acta Diabetol 52 845-216
[5]
Evans M(2017)Healthcare resource use, direct and indirect costs of hypoglycemia in type 1 and type 2 diabetes, and nationwide projections. Results of the HYPOS-1 study Nutr Metab Cardiovasc Dis 27 209-290
[6]
Parekh W(2009)Costs of managing severe hypoglycaemia in three European countries J Med Econ 12 281-671
[7]
Hoskins N(2011)The impact of non-severe hypoglycemic events on work productivity and diabetes management Value Health 14 665-351
[8]
Baker-Knight J(2016)Costs associated with emergency care and hospitalization for severe hypoglycemia Nutr Metab Cardiovasc Dis 26 345-175
[9]
de Arellano AR(2010)Self-monitoring of blood glucose (SMBG) in patients with type 2 diabetes on oral anti-diabetes drugs: cost-effectiveness in France, Germany, Italy, and Spain Curr Med Res Opin 26 163-639
[10]
Raya PM(2017)Evaluating drug cost per responder and number needed to treat associated with lixisenatide on top of glargine when compared to rapid-acting insulin intensification regimens on top of glargine, in patients with type 2 diabetes in the UK, Italy, and Spain J Med Econ 20 633-915